OrthoPediatrics Corp. (KIDS)
NasdaqGM · USD · Healthcare · Medical Devices
$24.02 (-1.96%) as of
Key statistics
- Market cap
- 627.16M
- Forward P/E
- -33.83
- EPS (TTM)
- -1.68
- Dividend yield
- 0.00%
- 52-week range
- 14.42 – 26.74
- Beta
- 0.99
- Revenue (TTM)
- 252.72M
- Profit margin
- -15.72%
- Analyst target
- $27.50
- Volume
- 378.06k
About OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Warsaw, IN, United States
- Employees
- 602
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.